SCHEMBL22971327

SCHEMBL22971327

c1cnc(Nc2ccc(N3CCOCC3)cn2)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ IKBKE Q14164 3/20 0.48
▸ TBK1 Q9UHD2 3/20 0.48
▸ CCND3 P30281 2/20 0.46
▸ CDK6 Q00534 2/20 0.46
▸ CCNK O75909 1/20 0.46
▸ CDK9 P50750 1/20 0.46
▸ EGFR P00533 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ LYN P07948 1/20 0.44
▸ SRC P12931 1/20 0.44
▸ CDK4 P11802 2/20 0.44
▸ CCND1 P24385 2/20 0.44
▸ PLK4 O00444 1/20 0.44
▸ CDK2 P24941 2/20 0.44
▸ CCNA2 P20248 1/20 0.44
▸ TYK2 P29597 3/20 0.43
▸ PCSK9 Q8NBP7 1/20 0.43
▸ JAK2 O60674 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30206206 0.86 PLK4 (0.59) NPC1RAB9APLK4JAK2SYK
SCHEMBL5256909 0.82 KARS1 (0.47) NPC1RAB9ACCND3CDK6CCNK
SCHEMBL22970759 0.80 CDK4 (0.47) NPC1RAB9AIKBKETBK1POLB
SCHEMBL22970904 0.80 CDK4 (0.49) NPC1RAB9AIKBKETBK1CDK6
SCHEMBL22970972 0.78 NPC1 (0.43) NPC1RAB9APLK4IGF1RMAPK10
SCHEMBL3137946 0.77 CYP1A1 (0.48) NPC1RAB9ACCND3CDK6CCNK
SCHEMBL16245666 0.77 CHRNB4 (0.50) NPC1RAB9ACCND3CDK6CCNK
Hydrochloric Acid SCHEMBL3134638 0.76 CYP1A1 (0.47) NPC1RAB9ACCND3CDK6CCNK
SCHEMBL12569861 0.76 POLB (0.51) NPC1RAB9ATBK1CCND3CDK6
SCHEMBL12952691 0.76 POLB (0.51) NPC1RAB9ACCND3CDK6CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210038607-A1 OXADIAZOLYLTHIOPHENE DERIVATIVES USEFUL AS HISTONE DEACETYLASE INHIBITORS KARUS THERAPEUTICS LIMITED (GB) 2021-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210038607-A1 OXADIAZOLYLTHIOPHENE DERIVATIVES USEFUL AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC5, HDAC3 NPC1 2871/4885RAB9A 3697/4885IKBKE 1670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback